The defibrillator market is expected to expand at a compound annual growth rate (CAGR) of 7% over the forecast period. This growth is driven by several key factors, including the rising prevalence of cardiovascular diseases, continuous technological innovations by leading manufacturers, greater public awareness of automated external defibrillators (AEDs), and strong support from governments and healthcare organizations. For more information on the research,
Download Sample PDF: https://meditechinsights.com/defibrillator-market/request-sample/
Defibrillators are devices used to deliver an electrical shock to the heart, with the goal of restoring a normal heartbeat. In cases of sudden cardiac arrest (SCA), these devices can be life-saving by restoring the heart’s normal rhythm. Sudden cardiac arrest is often fatal unless immediate actions like CPR (cardiopulmonary resuscitation) and defibrillation are taken.
There are three primary types of defibrillators:
- Automated External Defibrillators (AEDs): These are commonly found in public spaces and can be used by almost anyone to save lives during cardiac arrest.
- Implanted Cardioverter Defibrillators (ICDs): These devices are surgically implanted in the chest and automatically detect and treat life-threatening arrhythmias or cardiac arrest by delivering a powerful electric shock.
- Wearable Cardioverter Defibrillators (WCDs): WCDs are worn as vests that detect dangerous heart rhythms and, like ICDs, deliver a shock to restore a normal heartbeat.
Innovation Driving Market Growth
The increasing demand for advanced defibrillators is driving market expansion. Recent innovations in defibrillator technology have led to more efficient devices with longer battery life, smaller sizes, Bluetooth connectivity, and MRI compatibility, providing manufacturers with a competitive advantage. As a result, leading companies are investing heavily in research and development to create new products and expand their market reach. Notable examples include:
- Medtronic: In February 2023, Medtronic received CE approval for its Aurora EV-ICD MRI SureScan implantable defibrillator system and Epsila MRI SureScan, designed to treat irregular heart rhythms.
- MicroPort CRM: In May 2022, the company received approval from China’s NMPA for its Platinum implantable cardioverter defibrillator (ICD), which offers a lifespan of 13-14 years, reducing the need for frequent replacements.
- Zoll Medical Corporation: In July 2020, Zoll launched a new remote-view technology for its X Series monitor/defibrillator, enhancing its product portfolio.
- Jeevtronics Pvt Ltd: In July 2021, the company introduced the SanMitra 100 HCT, a hand-cranked dual-powered defibrillator designed for use in areas without electricity.
- Shenzhen Mindray Bio-medical Electronics: In September 2019, Mindray launched the BeneHeart C Series AED, featuring ResQNavi technology to guide users step-by-step through the resuscitation process with animated visuals and voice prompts.
Download Sample PDF: https://meditechinsights.com/defibrillator-market/request-sample/
Increasing Cardiovascular Disease Rates Drive Demand for Defibrillators
The growing prevalence of cardiovascular diseases (CVDs) is a major factor driving the defibrillator market. According to the British Heart Foundation, as of January 2022, the global prevalence of conditions like coronary heart disease, peripheral artery disease, stroke, and atrial fibrillation affects millions of people worldwide. In North America alone, 46 million people suffer from heart conditions, and globally, CVDs are responsible for 32% of all deaths, or 17.9 million deaths annually, as per the World Health Organization (WHO). In Europe, CVDs account for over 3.9 million deaths each year, with more than 1.8 million of these occurring in the European Union (EU).
Additionally, lifestyle factors such as poor diet, lack of exercise, smoking, and excessive alcohol consumption contribute to the rising incidence of heart disease and stroke. The aging population, who are more prone to heart conditions due to the natural wear and tear of the cardiovascular system, further exacerbates the issue. As the burden of CVDs grows, the demand for defibrillators to address sudden cardiac arrest increases.
Global Defibrillator Market Overview
As the global demand for defibrillators continues to rise, key market players like Medtronic, Boston Scientific, BIOTRONIK, Abbott, MicroPort, Stryker, Zoll Medical, and Philips are actively strengthening their market positions. The competitive landscape is evolving as companies adopt both organic and inorganic growth strategies, such as product approvals, mergers, and acquisitions, to expand their market share and access new technologies.
Some notable market movements include:
- Philips: In January 2022, Philips acquired Cardiologs, a French company, to enhance its cardiac diagnostic and monitoring offerings.
- Zoll Medical: In July 2020, Zoll, a subsidiary of Asahi Kasei, acquired Cardiac Science to strengthen its defibrillator portfolio and position itself as a leader in the cardiac care market.
- European Emergency Number Association (EENA): In 2020, EENA launched a project with Everdrone and Schiller to explore the use of drones for emergency medical deliveries, with Schiller contributing AEDs for the project.
The defibrillator market is poised for continued growth, driven by technological advancements, an increase in cardiovascular diseases, strategic acquisitions, and expanding healthcare infrastructure in emerging markets. As more defibrillators are placed in public spaces and healthcare systems invest in new technologies, the future of the defibrillator market looks promising.
Browse Report: https://meditechinsights.com/defibrillator-market/
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
